Author:
Lazar Shlomi,Neufeld-Cohen Adi,Egoz Inbal,Baranes Shlomi,Gez Rellie,Glick Pnina,Cohen Maayan,Gutman Hila,Chapman Shira,Gore Ariel
Reference86 articles.
1. Non-clinical studies in the process of new drug development - Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies;Andrade;Braz. J. Med. Biol. Res.,2016
2. The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302;Apland;J. Pharmacol. Exp. Ther.,2014
3. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment;Bajgar;Adv. Clin. Chem.,2004
4. Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury;Benavides;Curr. Protoc. Neurosci.,1999
5. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain;Chapman;Neurotoxicology,2006